4//SEC Filing
Agah Ramtin 4
Accession 0001641172-25-003631
CIK 0001574094other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:30 PM ET
Size
5.1 KB
Accession
0001641172-25-003631
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Purchase
Common Stock
2025-04-09$0.81/sh+30,000$24,399→ 1,078,460 total
Footnotes (2)
- [F1]Reflects open market purchases of the Issuer's securities.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
RenovoRx, Inc.
CIK 0001574094
Entity typeother
Related Parties
1- filerCIK 0001862617
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:30 PM ET
- Size
- 5.1 KB